Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT

This publication has 19 references indexed in Scilit:

• Gastrointestinal stromal tumors: Recent advances in understanding of their biology
  Published by Elsevier ,2004
• An Immunohistochemical Analysis of Endometrial Stromal and Smooth Muscle Tumors of the gUterus
  The American Journal of Surgical Pathology, 2002
• The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
  Blood, 2002
• Imatinib Mesylate — A New Oral Targeted Therapy
  New England Journal of Medicine, 2002
• Immunohistochemical Staining for KIT (CD117) in Soft Tissue Sarcomas Is Very Limited in Distribution
  American Journal of Clinical Pathology, 2002
• Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
  The Lancet, 2001
• Early Growth Response-1 Gene
  American Journal of Clinical Oncology, 2001
• Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy
  Leukemia Research, 2001
• The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma
  Cancer, 2000
• Uterine sarcomas in Norway 1956–1992: Incidence, survival and mortality
  European Journal Of Cancer, 1997